The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

The recent trial regarding the discontinued heartburn drug Zantac, which allegedly causes cancer, ended in a hung jury. The ...

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

GSK announced on Wednesday that it has reached confidential settlements in two lawsuits filed in California State Court ...

The carcinogen, known as NDMA, is not harmful in very small amounts. However, tests showed that there were excessive quantities of NDMA in Zantac, otherwise known as ranitidine. Multiple litigations ...

pointing to evidence from 12 epidemiological studies that show “there is no consistent or reliable evidence that ranitidine increases the risk of any cancer.” “Yesterday’s ruling reflects ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Diddy talks ‘freak off’ parties Video: Police subway shooting Things to do this weekend How to get the NYDN e-edition Today’s horoscope ...